逆转衰老可以治疗狼
Wenliang Pan1, George C Tsokos1
1Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
European journal of immunology
|July 20, 2024
概括
衰老的CD4+ T细胞,特别是CD4+CD57+细胞,与系统性红斑狼 (SLE) 活动有关,由中白素-15.5驱动. 老化药物治疗减少了易患狼的小鼠的自身免疫病理,这表明了新的SLE疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 这是一种自身免疫力.
- 细胞衰老 细胞衰老
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,其特征是免疫系统的失调.
- T细胞子集和功能的异常与SLE病变发生有关.
- 衰老的T细胞,特别是CD4+T细胞的积累,越来越多地被认为是导致SLE发展的因素.
研究的目的:
- 研究衰老的CD4+T细胞在系统性红斑狼 (SLE) 中的作用.
- 在SLE患者中探索CD4+CD57+衰老T细胞,疾病活性和中白素-15之间的关联.
- 在SLE的临床前模型中评估老化药物的治疗潜力.
主要方法:
- 流细胞计用于量化SLE患者的CD4+CD57+衰老T细胞.
- 测量了中白素-15水平,并与T细胞子集和疾病活性相关联.
- 易患狼的小鼠接受了老化药物治疗,并评估了随后的自身免疫病理.
主要成果:
- 在患有SLE的患者中,发现了CD4+CD57+衰老T细胞的扩大池.
- 这些衰老的T细胞的扩张与SLE疾病活性相关,并与升高的IN-15水平有关.
- 在易患狼的小鼠中,老年化药物治疗导致了自身免疫病理的显著减少.
结论:
- 扩张的CD4+CD57+衰老的T细胞,受15型白内素的影响,涉及到SLE的发病.
- 老化疗法显示出作为一种新的治疗策略来管理SLE的潜力.
- 向衰老的T细胞可能为治疗系统性红斑狼患者提供新的途径.
相关概念视频
Aging
41
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
41
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418


